The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:uu-110611" > The glucocorticoid ...

1 of 1
Previous record
Next record
To hitlist

The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors

Tacon, Lyndal J. (author)

Soon, Patsy S. (author)

Gill, Anthony J. (author)

Chou, Angela S. (author)

Clarkson, Adele (author)

Botling, Johan (author): Uppsala universitet,Institutionen för genetik och patologi

Stålberg, Peter L. H. (author): Uppsala universitet,Endokrinkirurgi

Skogseid, Britt M. (author): Uppsala universitet,Institutionen för medicinska vetenskaper,Endokrin tumörbiologi

Robinson, Bruce G. (author)

Sidhu, Stanley B. (author)

Clifton-Bligh, Roderick J. (author)

show less...

(creator_code:org_t)

The Endocrine Society, 2009
2009
English.
In: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 94:11, s. 4591-4599

Related links:: https://academic.oup...; show more...; https://urn.kb.se/re...; https://doi.org/10.1...; show less...

Journal article (peer-reviewed)

Abstract Subject headings

CONTEXT: Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. The Weiss score is the most widely accepted method for distinguishing an ACC from an adrenocortical adenoma (ACA); however, in borderline cases, accurate diagnosis remains problematic. We recently discovered that the glucocorticoid receptor (GR) gene NR3C1 is significantly up-regulated in ACCs compared with ACAs in global gene expression studies. OBJECTIVE: Our objective was to study GR expression in adrenocortical tumors (ACTs) and to assess its utility as an adjunct to the Weiss score. DESIGN: Microarray analysis, real-time quantitative RT-PCR (qPCR), immunohistochemistry, Western blot, and direct sequencing were performed. RESULTS: Analysis of 28 ACTs by microarray and 49 ACTs by qPCR found NR3C1 expression to be up-regulated in ACCs compared with ACAs (P < 0.001). Western blotting and RT-PCR confirmed the presence of the GRalpha isoform in ACCs, and no mutations were detected on direct sequencing. Immunohistochemistry for GR in an overlapping cohort of ACTs demonstrated strongly positive nuclear staining in 31 of 33 ACCs (94%), with negative staining in 40 of 41 ACAs (98%) (P < 0.001). This finding was validated in an external cohort of ACTs, such that 14 of 18 ACCs (78%) demonstrated positive nuclear staining whereas 32 of 33 ACAs (94%) were negative (P < 0.001). CONCLUSIONS: The immunohistochemical finding of nuclear GR staining identified ACCs with high diagnostic accuracy. We propose that GR immunohistochemistry may complement the Weiss score in the diagnosis of ACC in cases that display borderline histology. The possibility that GR is transcriptionally active in these tumors, and may therefore be a therapeutic target, requires further study.

Keyword

MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

Journal of Clinical Endocrinology and Metabolism (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Tacon, Lyndal J.; Soon, Patsy S.; Gill, Anthony J.; Chou, Angela S.; Clarkson, Adele; Botling, Johan; show more...; Stålberg, Peter ...; Skogseid, Britt ...; Robinson, Bruce ...; Sidhu, Stanley B ...; Clifton-Bligh, R ...; show less...

Articles in the publication: Journal of Clini ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se